AURKA is one of the downstream targets of MAPK1/ERK2 in pancreatic cancer
The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
DUSP6/MKP-3, a specific inhibitor of MAPK1/ERK2, frequently loses its expression in primary pancreatic cancer tissues. This evidence suggests that constitutive activation of MAPK1 synergistically induced by frequent mutation of KRAS2 and the loss of function of DUSP6 plays key roles in pancreatic carcinogenesis and progression. By profiling of gene expressions associated with downregulation of MAPK1 induced by exogenous overexpression of DUSP6 in pancreatic cancer cells, we found that AURKA/STK15, the gene encoding Aurora-A kinase, which plays key roles in cellular mitosis, was among the downregulated genes along with its related genes, which included AURKB, TPX2 and CENPA. An association of expression and promoter activity of AURKA with MAPK activity was verified. Knockdown of ETS2 resulted in a reduction of AURKA expression. These results indicate that AURKA is a direct target of the MAPK pathway and that its overexpression in pancreatic cancer is induced by hyperactivation of the pathway, at least via ETS2.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“On one hand, aberrant activation of KRAS and downstream MAPK/ERK signaling promotes AURKA overexpression [129–131].”
From Differential Response and Resistance to KRAS-Targeted Therapy (2025) · cites this paper as [131]
Citations
Cites
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456 · cited 2×
“…residues (dTdT) overhanging at the 30 end to knock down the expressions of ETS2, ELK1 and LMNA, including 50-CAACAGGCUUGGAUUCCAU-30 for ETS2, 50-GGCAAUGGCCACAUCAUCU-30 for ELK1 and 50-CUGGACUUCCAGAAGAACA-30 for LMNA (Elbashir et al., 2001), were purchased from Japan Bioservice (Asaka, Japan).”
MethodProtein kinases and phosphatases: The Yin and Yang of protein phosphorylation and signaling
Hunter, T. (1995) · Cell · doi:10.1016/0092-8674(95)90405-0 · Cited by 2,950
Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation
Zhou, H., Kuang, J., Zhong, L., Kuo, W.-L., Gray, J., Sahin, A., Brinkley, B., & Sen, S. (1998) · Nature Genetics · doi:10.1038/2496 · Cited by 1,276 · cited 1×
“AURKA encodes AURKA/STK15/ Aurora-A kinase, which is an essential molecule involved in regulating the functions of centrosomes, spindles and kinetochores and is therefore required for proper mitosis of cells (Zhou et al., 1998; Marumoto et al., 2005).”
BackgroundWang, Y., Cortez, D., Yazdi, P., Neff, N., Elledge, S. J., & Qin, J. (2000) · Genes & Development · doi:10.1101/gad.14.8.927 · Cited by 1,221
A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers
Bischoff, J. R. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3052 · Cited by 1,216 · cited 1×
“…is overexpressed in various cancer cells, including pancreatic cancer, and is associated with high-grade of tumors and poor survival of patients with cancer (Sen et al., 1997; Bischoff et al., 1998; Tanner et al., 2000; Miyoshi et al., 2001; Li et al., 2003; Jeng et al., 2004; Tong et al., 2004).”
BackgroundTargeting the mitogen-activated protein kinase cascade to treat cancer
Sebolt-Leopold, J. S., & Herrera, R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1503 · Cited by 1,108
Protein phosphatases and the regulation of mitogen-activated protein kinase signalling
Keyse, S. M. (2000) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)00075-7 · Cited by 807 · cited 1×
“DUSP6 is a phosphatase strictly specific for MAPK1; it forms a feedback loop for physiological regulation of MAPK activity (Keyse, 2000).”
BackgroundAurora-A — A guardian of poles
Marumoto, T., Zhang, D., & Saya, H. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1526 · Cited by 697 · cited 5×
“2; however, an overexpression without gene amplification is also frequently observed (Marumoto et al., 2005).”
BackgroundInfluentialMolecular biology of the Ets family of transcription factors
Oikawa, T., & Yamada, T. (2003) · Gene · doi:10.1016/s0378-1119(02)01156-3 · Cited by 688 · cited 2×
“ETS2 is a transcription factor belonging to the ETS family of transcription factors (Oikawa and Yamada, 2003).”
BackgroundHunter, T., & Pines, J. (1991) · Cell · doi:10.1016/0092-8674(91)90028-w · Cited by 688 · cited 2×
“They included genes encoding cyclins such as CCNA2, CCNB1, CCNB2 and CCNE2 (Hunter and Pines, 1991), kinetocore-related molecules such as AURKA, AURKB, CENPA and CENPF (Hussein and Taylor, 2002; Kunitoku et al., 2003; Marumoto et al., 2005), microtubule-associated molecules such as TPX2 and KIF2C (Kufer et al., 2002;…”
Background
Cited by
Roles of Aurora Kinases in Mitosis and Tumorigenesis
Fu, J., Bian, M., Jiang, Q., & Zhang, C. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0208 · Cited by 614
“Aurora Kinases in Other Signaling Pathways and Tumorigenesis Recent studies found that Aurora-A is a downstream target of mitogen-activated protein kinase 1/ER2 in pancreatic cancer (101).”
BackgroundHung, L.-Y., Tseng, J. T., Lee, Y.-C., Xia, W., Wang, Y.-N., Wu, M.-L., Chuang, Y.-H., Lai, C.-H., & Chang, W.-C. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn417 · Cited by 196
“Furthermore, the DUSP6/MKP-3 (dual specificity phosphatase 6/MAPK phosphatase-3, a candidate tumor suppressor gene and a specific phosphatase forMAPK1), can downregulateAurora-A gene expression in pancreatic cancer (11).”
BackgroundWidodo, N., Priyandoko, D., Shah, N., Wadhwa, R., & Kaul, S. C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013536 · Cited by 157
“TPX2 is a microtubule-associated protein that functions as an allosteric regulator of Aurora-A, an oncogene with essential role in centrosome maturation and chromosome segregation during mitosis requiring assembly and maintenance of a bipolar spindle [21–23].”
BackgroundThe long non-coding RNA HOTTIP enhances pancreatic cancer cell proliferation, survival and migration
Cheng, Y., Jutooru, I., Chadalapaka, G., Corton, J. C., & Safe, S. H. (2015) · Oncotarget · doi:10.18632/oncotarget.3450 · Cited by 150
“Since AURKA (Aurora-A kinase) plays an important multifunctional role in pancreatic cancer [19–21], we further investigated the function and regulation of AURKA in pancreatic cancer cells.”
BackgroundMuhammad, K. A., Nur, A. A., Shafie, N. H., Narazah, M. Y., & Razak, S. R. A. (2018) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2017.0107 · Cited by 154
Exome-Scale Discovery of Hotspot Mutation Regions in Human Cancer Using 3D Protein Structure
Tokheim, C., Bhattacharya, R., Niknafs, N., Gygax, D. M., Kim, R., Ryan, M., Masica, D. L., & Karchin, R. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3190 · Cited by 132
“Candidate OG in pancreatic cancer (25), laryngeal squamous”
BackgroundAurora kinase A in gastrointestinal cancers: time to target
Katsha, A. M., Belkhiri, A., Goff, L. W., & El-Rifai, W. M. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0375-4 · Cited by 127
“Interestingly, while it was shown in colorectal cancer that AURKA regulates MEK/ERK pathway [63], it was reported that AURKA is a downstream target of this pathway in pancreatic cancer [73], raising the possibility of an existing positive feedback loop between AURKA and MEK/ERK pathway.”
BackgroundValidation of TPX2 as a Potential Therapeutic Target in Pancreatic Cancer Cells
Warner, S. L., Stephens, B. J., Nwokenkwo, S., Hostetter, G. H., Sugeng, A., Hidalgo, M. M., Trent, J. M., Han, H., & Hoff, D. D. V. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0077 · Cited by 114
Biology of Aurora A kinase: Implications in cancer manifestation and therapy
Dhanasekaran, K., Prasad, S. B. B., Shandilya, J., Agrawal, S., & Kundu, T. K. (2010) · Medicinal Research Reviews · doi:10.1002/med.20203 · Cited by 111
“However, the functional outcome is yet to be discovered.(28) 762 K KARTHIGEYAN ETAL.”
BackgroundTPX2 is a novel prognostic marker for the growth and metastasis of colon cancer
Wei, P., Zhang, N., Xu, Y., Li, X., Shi, D., Wang, Y., Li, D., & Cai, S. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-313 · Cited by 108
“treatment in Non-Hodgkin’s lymphoma [25,26].”
Wan, X.-B., Long, Z.-J., Yan, M., Xu, J., Xia, L.-P., Liu, L., Zhao, Y., Huang, X.-F., Wang, X.-R., Zhu, X.-F., et al. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn176 · Cited by 105
EGFRvIII expression and PTEN loss synergistically induce chromosomal instability and glial tumors
Li, L., Dutra, A., Pak, E. D., Labrie, J. E., Gerstein, R. M., Pandolfi, P. P., Recht, L. D., & Ross, A. H. (2009) · Neuro-Oncology · doi:10.1215/15228517-2008-081 · Cited by 110
Qin, Y., Zhang, S., Deng, S., An, G. C., Qin, X., Li, F., Xu, Y., Hao, M., Yang, Y., Zhou, W., et al. (2016) · Leukemia · doi:10.1038/leu.2016.325 · Cited by 101
Tang, J., Karhinen, L., Xu, T., Szwajda, A., Yadav, B., Wennerberg, K., & Aittokallio, T. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003226 · Cited by 91
“Among these targets, PDGFRA and MET (marked with red arrows) were experimentally validated in the original work [56].”
MethodHDAC2 promotes loss of primary cilia in pancreatic ductal adenocarcinoma
Kobayashi, T., Nakazono, K., Tokuda, M., Mashima, Y., Dynlacht, B. D., & Itoh, H. (2017) · The EMBO Reports · doi:10.15252/embr.201541922 · Cited by 75
“In PDAC cells, Aurora A transcription is positively regulated by the ETS2 transcription factor, which is activated by the Kras – MAPK1 pathway [30].”
Impacts of Activation of the Mitogen-Activated Protein Kinase Pathway in Pancreatic Cancer
Furukawa, T. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00023 · Cited by 70
“Knockdown of ETS2 induces downregulation of AURKA (24).”
BackgroundSelf-citationMicroRNAs Associated with Mitogen-Activated Protein Kinase in Human Pancreatic Cancer
Ikeda, Y., Tanji, E., Makino, N., Kawata, S., & Furukawa, T. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0035 · Cited by 70
“Cell culture Human pancreatic cancer cell lines,MIAPaCa-2, PCI-35, PK-8, Panc-1, and AsPC-1, as well as the human kidney epithelial cell line HEK293 were obtained and cultured as previously described (8).”
BackgroundMethodSelf-citationAurora kinase inhibitors as anti-cancer therapy
Lok, W., Klein, R. Q., & Saif, M. W. (2010) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e3283350dd1 · Cited by 75
Patel, A. V., Eaves, D. W., Jessen, W. J., Rizvi, T. A., Ecsedy, J., Qian, M. G., Aronow, B. J., Perentesis, J. P., Serra, E., Cripe, T. P., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1072 · Cited by 72
“naling (37), was identified by Bayesian analysis as a Schwann cell H-Ras target overexpressed in mouse and human MPNSTs but to a much lesser extent in”
BackgroundOvercoming cetuximab resistance in HNSCC: The role of AURKB and DUSP proteins
Boeckx, C., de Beeck, K. O., Wouters, A., Deschoolmeester, V., Limame, R., Zwaenepoel, K., Specenier, P. M., Pauwels, P., Vermorken, J. B., Peeters, M., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.08.039 · Cited by 68
“This pathway tightly regulates cellular responses from various physiological stimuli and plays a key role in carcinogenesis of different tumor types, for instance in pancreas and lung cancer [41,50].”
InfluentialThe potential role of Aurora kinase inhibitors in haematological malignancies
Farag, S. S. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08898.x · Cited by 64
“For example, Aurora A is a downstream target of MAPK1/ERK, and constitutive activation of MAPK1 ª 2011 Blackwell Publishing Ltd, British Journal of Haematology, 155, 561–579 565 in pancreatic cancer has been reported to result in overexpression of Aurora A (Furukawa et al, 2006).”
BackgroundTranscriptional regulation of miR-196b by ETS2 in gastric cancer cells
Liao, Y.-L., Hu, L., Tsai, K., Wu, C.-W., Chan, W., Li, S., Lai, C.-H., Ho, M., Fang, W., Huang, K., et al. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs023 · Cited by 69
Potential new biomarkers for endometrial cancer
Townsend, M. H., Ence, Z. E., Felsted, A. M., Parker, A., Piccolo, S., Robison, R. A., & O'Neill, K. L. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0731-3 · Cited by 60
“AURKA has been shown to be a downstream target of MAPK1, which is a major force in cellular proliferation in several cancer cells [16].”
BackgroundMolecular pathology of pancreatic cancer
Saiki, Y., & Horii, A. (2014) · Pathology International · doi:10.1111/pin.12114 · Cited by 57
Self-citationPuig-Butille, J. A., Vinyals, A., Ferreres, J. R., Aguilera, P., Cabré, E., Tell-Martí, G., Marcoval, J., Mateo, F., Palomero, L., Badenas, C., et al. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.01.021 · Cited by 58
“The proximal region spanning between -90 and the major TIS contains a consensus sequence (GGAA) for the ETS family of transcription factors embedded in the binding sequence of the E4TF1 element (CCTTAAG), as described previously (Furukawa et al. 2006).”
BackgroundMethodAurora kinase A (AURKA) interaction with Wnt and Ras-MAPK signalling pathways in colorectal cancer
Jacobsen, A., Bosch, L. J. W., Kemp, S. R. M., Carvalho, B. G., Sillars-Hardebol, A. H., Dobson, R., de Rinaldis, E., Meijer, G. A., Abeln, S., Heringa, J., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-24982-z · Cited by 58
Aberrantly expressed AURKC enhances the transformation and tumourigenicity of epithelial cells
Tsou, J., Chang, K., Chang‐Liao, P., Yang, S., Lee, C., Chen, Y., Lee, Y., Lin, B., Lee, J., Shen, M., et al. (2011) · The Journal of Pathology · doi:10.1002/path.2934 · Cited by 58
Dawei, H., Honggang, D., & Qian, W. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.10.170 · Cited by 54
Wang, J. M., Liu, L., & Brinton, R. D. (2007) · Endocrinology · doi:10.1210/en.2007-1155 · Cited by 52
Rajput, A. B., Hu, N., Varma, S., Chen, C., Ding, K., Park, P. C., Chapman, J.-A. W., Sengupta, S., Madarnas, Y., Elliott, B. E., et al. (2011) · Cancers · doi:10.3390/cancers3044212 · Cited by 50
“DUSP6 over-expressing cells showed down-regulation of several genes regulating mitosis including AURKB, TPX2 and CENPA [23], lending further support to the idea that CENPA plays a role in carcinogenesis.”
BackgroundKuonen, F., Huskey, N. E., Shankar, G., Jaju, P. D., Whitson, R. J., Rieger, K. E., Atwood, S. X., Sarin, K. Y., & Oro, A. E. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.11.035 · Cited by 52
“Alternatively, Ras pathway activation was reported to induce primary cilia disassembly and reduce HH pathway activation through the induction of Aurora kinase and Dyrk1b, respectively (Furukawa et al., 2006; Kobayashi et al., 2017; Lauth et al., 2010; Seeley et al., 2009), suggesting that restoring ciliogenesis may re…”
BackgroundFeedback regulation of DUSP6 transcription responding to MAPK1 via ETS2 in human cells
Furukawa, T., Tanji, E., Xu, S., & Horii, A. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.10.003 · Cited by 49
Self-citationEWS-Fli1 Up-Regulates Expression of the Aurora A and Aurora B Kinases
Wakahara, K., Ohno, T., Kimura, M., Masuda, T., Nozawa, S., Dohjima, T., Yamamoto, T., Nagano, A., Kawai, G., Matsuhashi, A., et al. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0054 · Cited by 49
“Aurora A and B, a highly conserved family of serine/ threonine protein kinases, are tightly regulated during the cell cycle and are overexpressed in many carcinomas, such as hepatocellular, ovarian, esophageal, bladder, breast, prostate, pancreas, and lung cancers (24-34).”
BackgroundMethodDUSP6 mediates resistance to JAK2 inhibition and drives leukemic progression
Kong, T., Laranjeira, A. B. A., Yang, K., Fisher, D. A. C., Yu, L. C., Frégonnière, L. P. D. L., Wang, A. Z., Ruzinova, M. B., Fowles, J. S., Fulbright, M. C., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00486-8 · Cited by 63
The Effects of Plumbagin on Pancreatic Cancer: A Mechanistic Network Pharmacology Approach
Pan, Q., Zhou, R., Su, M., & Li, R. (2019) · Medical Science Monitor · doi:10.12659/msm.917240 · Cited by 44
“Studies have shown that overexpression of MAPK1 is found in primary PC and is associated with poor prognosis following chemotherapy [15].”
BackgroundTabata, T., Tsukamoto, N., Fooladi, A. A. I., Yamanaka, S., Furukawa, T., Ishida, M., Sato, D., Gu, Z., Nagase, H., Egawa, S., et al. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.09.096 · Cited by 40
“Gene expression profiling was analyzed by methods described previously [18] using the CodeLink Uniset Human 20 K I Bioarray System (GE Healthcare, Piscataway, NJ).”
MethodSelf-citationUmene, K., Yanokura, M., Banno, K., Irie, H., Adachi, M., Iida, M., Nakamura, K., Nogami, Y., Masuda, K., Kobayashi, Y., et al. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.2842 · Cited by 43
Li, B., Qi, X., Chen, X., Huang, X., Liu, G., Chen, H., Huang, C.-G., Luo, C., & Lu, Y. (2010) · Brain Research · doi:10.1016/j.brainres.2010.06.060 · Cited by 37
“P53 is able to inhibit AURKA activity (Furukawa et al., 2006) and this inhibitory effect can be suppressed by the prior binding of AURKA to TPX2 (Eyers and Maller, 2004).”
A Review of Kinases Implicated in Pancreatic Cancer
Giroux, V., Dagorn, J., & Iovanna, J. (2009) · Pancreatology · doi:10.1159/000199435 · Cited by 39
Rengifo-Cam, W., Umar, S., Sarkar, S., & Singh, P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1206 · Cited by 35
Yang, C., You, D., Huang, J. X., Yang, B., Huang, X., & Ni, J. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28398 · Cited by 34
“AURKA, one of the members of the Aurora kinase family, encodes AurkA/STK15/AuroRa kinases, which are essential for centrosome regulation and spindle and kinetochore function (Furukawa et al., 2006).”
BackgroundTranslational up‐regulation of Aurora‐A in EGFR‐overexpressed cancer
Lai, C.-H., Tseng, J. T.-C., Lee, Y., Chen, Y., Lee, J.-C., Lin, B., Huang, T., Liu, Y., Leu, T., Liu, Y., et al. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00919.x · Cited by 38
“Interestingly, it was reported that the activated MAPK pathway may directly up-regulate the Aurora-A gene in pancreatic cancer [28].”
BackgroundQuist, J., Mirza, H., Cheang, M. C. U., Telli, M. L., O’Shaughnessy, J., Lord, C. J., Tutt, A. N. J., & Grigoriadis, A. E. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-0243 · Cited by 32
“To further corroborate the lack of negative regulation of MAPK inactivation, a set of genes previously reported under control of this inhibitory mechanism (40) was interrogated in the MC subtypes and found increased in MC6-TNBCs compared with TNBCs of other MC subtypes (P < 0.”
Gene knockdown of CENPA reduces sphere forming ability and stemness of glioblastoma initiating cells
Behnan, J., Grieg, Z., Joel, M., Ramsnes, I., & Stangeland, B. (2016) · Neuroepigenetics · doi:10.1016/j.nepig.2016.08.002 · Cited by 31
“…(Zhang et al., 2014; Habel et al., 2013; Toh et al., 2011; Rajput et al., 2011; Hu et al., 2010; Biermann et al., 2007a; Biermann et al., 2007b; Furukawa et al., 2006; Li et al., 2007; Tomonaga et al., 2003; Qiu et al., 2013) and has been suggested as a potential therapeutic target (Stangeland…”
BackgroundInfluentialTseng, Y.-S., Lee, J. C., Huang, C. F., & Liu, H. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-435 · Cited by 32
“, (2006) showed that Aurora-A is one of the downstream targets of MAPK signaling [40].”
BackgroundPrognostic significance of Aurora-A expression in human bladder cancer
Yu, L., Yan, S., Lei, M., Na, L., & Han, R. (2010) · Acta Histochemica · doi:10.1016/j.acthis.2010.05.004 · Cited by 30
Molecular Pathology of Pancreatic Cancer: Implications for Molecular Targeting Therapy
Furukawa, T. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.07.035 · Cited by 33
Self-citationA New Aurora in Anaplastic Thyroid Cancer Therapy
Baldini, E., D’Armiento, M., & Ulisse, S. (2014) · International Journal of Endocrinology · doi:10.1155/2014/816430 · Cited by 29
“As above described, the AURKB promoter may be positively regulated by transcription factors such as the ETS2 via ETS-binding sites present in the promoter sequence [15, 16].”
BackgroundOncogenic role of nuclear accumulated Aurora‐A
Tatsuka, M., Sato, S., Kanda, A., Miki, T., Kamata, N., Kitajima, S., Kudo, Y., & Takata, T. (2009) · Molecular Carcinogenesis · doi:10.1002/mc.20525 · Cited by 33
“activation of the MAPK pathway, which is commonly activated in cancer cells, has been suggested [17].”
BackgroundAurora kinase A interacts with H-Ras and potentiates Ras-MAPK signaling
Umstead, M., Xiong, J., Qi, Q., Du, Y., & Fu, H. (2017) · Oncotarget · doi:10.18632/oncotarget.15049 · Cited by 29
“Additionally, modulation of ERK activity and the ETS promoter alters Aurora A expression, indicating that MAPK signaling regulates transcription of Aurora A [18].”
BackgroundZhao, Q. C., Zhang, Y., Shao, S., Sun, Y., & Lin, Z. (2021) · PeerJ · doi:10.7717/peerj.10594 · Cited by 31
“In fact, elevated AURKA expression was observed in several human cancers, such as pancreatic cancer, endometrioid ovarian carcinoma and colorectal cancer liver metastasis, and was associated with poor prognosis (Furukawa et al., 2006).”
BackgroundDifferential expression of aurora-A kinase in T-cell lymphomas
Kanagal‐Shamanna, R., Lehman, N. L., O’Donnell, J. P., Lim, M. S., Schultz, D. S., Chitale, D. A., Bueso-Ramos, C., Medeiros, L. J., & Inamdar, K. V. (2013) · Modern Pathology · doi:10.1038/modpathol.2012.211 · Cited by 28
Geng, R., Li, N., Xu, Y., Liu, J., Yuan, F.-E., Sun, Q., Liu, B., & Chen, Q. (2018) · Disease Markers · doi:10.1155/2018/3215958 · Cited by 26
“located on chromosome 20q13, frequently amplified and overexpressed in human malignancies, involving breast cancer [17], pancreatic cancer [18], and gastric cancer [19].”
BackgroundOgawa, T., Ogawa, K., Shiga, K., Furukawa, T., Nagase, H., Hashimoto, S., Kobayashi, T., & Horii, A. (2010) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-010-1257-4 · Cited by 25
“Two microarray platforms were used; one was cDNA microarray slides (Amersham Biosciences, Piscataway, NJ, USA) fabricated by spotting 23,040 unique cDNAs as described [10], and the other was the CodeLink Uniset Human 20K I Bioarray System (Amersham Biosciences) harboring 19,881 human genes as described [11].”
MethodSelf-citationThe PMAIP1 Gene on Chromosome 18 is a Candidate Tumor Suppressor Gene in Human Pancreatic Cancer
Ishida, M., Sunamura, M., Furukawa, T., Lefter, L. P., Morita, R., Akada, M., Egawa, S., Unno, M., & Horii, A. (2008) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-0154-1 · Cited by 24
Self-citationAnalysis of potential genes associated with primary cilia in bladder cancer
Du, E., Lü, C., Sheng, F., Li, C., Li, H., Ding, N., Chen, Y., Zhang, T., Yang, K., & Xu, Y. (2018) · Cancer Management and Research · doi:10.2147/cmar.s175419 · Cited by 27
TPX2 siRNA regulates growth and invasion of esophageal cancer cells
Liu, H., Zhang, G.-H., Liu, Y., Wang, P., Ma, J.-F., Su, L., Li, S., Zhang, L., & Liu, J.-W. (2014) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2014.08.008 · Cited by 23
Aurora and IKK kinases cooperatively interact to protect multiple myeloma cells from Apo2L/TRAIL
Mazzera, L., Lombardi, G., Abeltino, M., Ricca, M., Donofrío, G., Giuliani, N., Cantoni, A. M., Corradi, A., Bonati, A., & Lunghi, P. (2013) · Blood · doi:10.1182/blood-2013-02-482356 · Cited by 24
Network Understanding of Herb Medicine via Rapid Identification of Ingredient-Target Interactions
Zhang, H., Pan, J., Zhang, C., Ji, N., Wang, H., & Ji, Z. (2014) · Scientific Reports · doi:10.1038/srep03719 · Cited by 23
Zhang, Y., Lin, Z., Lin, X., Zhang, X., Zhao, Q. C., & Sun, Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-84837-y · Cited by 29
Chien, C., Tsai, H.-T., Su, L., Chuang, H., Shiu, L., Huang, C.-C., Fang, F.-M., Yu, C.-C., Su, H.-T., & Chen, C.-H. (2014) · Oncotarget · doi:10.18632/oncotarget.1896 · Cited by 21
“Recently, MAPK, such as ERK, was reported to regulated Aurora-A expression in pancreatic cancer cell and nasopharyngeal carcinoma cell[38, 46].”
BackgroundMechanisms of development and progression of pancreatic neoplasms
Furukawa, T. (2022) · Pathology International · doi:10.1111/pin.13272 · Cited by 21
“We showed that AURKA was frequently overexpressed in pancreatic cancer due to upregulation of its promoter by active MAPK via Ets‐2.(24) Downregulation of AURKA by RNA interference significantly suppressed the proliferation and survival of pancreatic cancer cells, and the downregulation of AURKA enhanced the effect of…”
BackgroundSelf-citationJia, L., Lee, H. S., Wu, C. F., Kundu, J., Park, S. G., Kim, R. N., Wang, L., Erkin, Ö. C., Choi, J., Chae, S. W., et al. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0191 · Cited by 21
“Aurora A kinase (AURKA), a centrosomal serine/threonine protein kinase, is overexpressed and localized to centrosomes during interphase and to spindle poles during mitosis because of constitutive phosphorylation (12) through activation of oncogenic RAS (13) and the MAPK pathway (14).”
BackgroundInfluentialKao, S., Chen, Y., Tu, H., Liu, C., Yu, A., Wu, C., & Chang, K. (2010) · The Journal of Pathology · doi:10.1002/path.2737 · Cited by 20
Furukawa, T., Tanji, E., Kuboki, Y., Hatori, T., Yamamoto, M., Shimizu, K., Shibata, N., & Shiratori, K. (2012) · Molecular Cancer · doi:10.1186/1476-4598-11-88 · Cited by 20
“In a previous study, we screened the genome for downstream targets of MAPK and identified 78 molecules specifically associated with MAPK activity in pancreatic cancer cells [9].”
InfluentialSelf-citationInchanalkar, S., Deshpande, N. U., Kasherwal, V., Jayakannan, M., & Balasubramanian, N. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00163 · Cited by 17
Hao, J., Shi, Z., Zhao, Z.-X., Zhang, Y., Gong, T., Li, C., Zhan, T., Cai, Y., Dong, J., Fu, S., et al. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-367 · Cited by 19
“Recent studies have reported that AURKA is a direct target of the MAPK pathway [52].”
BackgroundAURKB and MAPK involvement in the regulation of the early stages of mouse zygote development
Lin, X., Liu, T., Han, F., Zong, Z., Wang, G., Yu, B., & Zhang, J. (2012) · Science China Life Sciences · doi:10.1007/s11427-012-4264-4 · Cited by 17
Meng, J., Liu, H., Ma, D., Wang, H., Yue, P., & Wang, H. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118491 · Cited by 18
Functional Significance of Aurora Kinase A in Centrosome Amplification and Genomic Instability
Sen, S., Katayama, H. G., & Sasai, K. (2008) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-69080-3_9 · Cited by 18
Response of experimental malignant melanoma models to the pan‐Aurora kinase inhibitor VE‐465
Pirker, C., Lötsch, D., Spiegl‐Kreinecker, S., Jantscher, F., Sutterlüty, H., Micksche, M., Grusch, M., & Berger, W. (2010) · Experimental Dermatology · doi:10.1111/j.1600-0625.2010.01182.x · Cited by 16
Pancreatic adenocarcinoma protein-protein interaction network analysis.
Rezaei–Tavirani, M., Rezaei-Tavirani, S., Ahmadi, N., Naderi, N., & Abdi, S. (2017) · Gastroenterology and hepatology from bed to bench. · Cited by 16
Bangs, F. K., Miller, P. F., & O’Neill, E. E. (2020) · Disease Models & Mechanisms · doi:10.1242/dmm.044289 · Cited by 17
“Indeed, AurkA is regulated by KRAS via the MAPK signalling pathway, and, consequently, AurkA is ectopically expressed in pancreatic cancer and KRAS knockdown in PDAC cell lines leads to depletion of AurkA and cilia formation (Furukawa et al., 2006; Li et al., 2003; Kobayashi et al., 2016).”
Inhibition of Mitogen-activated Protein Kinase Phosphatase 3 Activity by Interdomain Binding
Mark, J. K., Aubin, R. A., Smith, S., & Hefford, M. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801747200 · Cited by 12
Liu, Y., Jin, Z., Huang, X., Che, Y.-C., & Liu, Q. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.553536 · Cited by 11
“Another kinase, AURKA, participates in pancreatic carcinogenesis via the MAPK1/ERK2 signaling pathway (86).”
BackgroundPan, C., Zhu, Y., Yu, M., Zhao, Y., Zhang, C., Zhang, X., & Yao, Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.633579 · Cited by 13
“Meanwhile, among these 10 indispensable nodes, MAX, AURKA, YEATS4, and NMI are the nodes directly associated with MYCN, these proteins are present in the first-order egocentric network of MYCN and have close interactions with MYCN.”
BackgroundInfluentialWang, L., Chen, E., Zhang, S., Xiang, W., Ye, H., Fu, Y., Xu, S., Wang, Q., Tao, Y., Yang, D., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08156-0 · Cited by 10
Zhang, Q., Tang, Y., Sun, S., Xie, Q., Yao, J. J., Wang, X., Qian, J., & Li, Z. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03756-2 · Cited by 10
“A study has reported that AURKA may be a downstream target of the MEK/ERK pathway in PC [42].”
BackgroundERK1-mediated immunomodulation of mesenchymal stem cells ameliorates inflammatory disorders
Zhang, Q. H., Lei, X., Wang, F., He, X., Liu, L., Hou, Y., Liu, Y., Jin, F., Chen, C., & Li, B. (2023) · iScience · doi:10.1016/j.isci.2023.107868 · Cited by 10
“37,38 InMSCT, ETS genes have been reported as targets for the protection and regeneration of cardiac muscle and bone matrix by MSCs or their exosomes.”
Tiong, K.-L., Sintupisut, N., Lin, M.-C., Cheng, C.-H., Woolston, A., Lin, C.-H., Ho, M., Lin, Y., Padakanti, S., & Yeang, C. (2022) · PLOS Digital Health · doi:10.1371/journal.pdig.0000151 · Cited by 12
Protective effects and mechanism of TPX2 on neurocyte apoptosis of rats in Alzheimer's disease model
Liang, K., Zhang, J., Yin, C.-B., Zhou, X., & Zhou, S. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.4006 · Cited by 9
“Through the maintenance of normal spindle polarity and analysis of related gene expression profile of exogenous overexpression of DUSP6 in pancreatic cancer cells, Furukawa and colleagues found that AURKA/STK15 gene encoding the Aurora-A kinase gene plays an important role in cell division and leads to a decrease in g…”
BackgroundChung, T. T., Piao, Z., & Lee, S. (2025) · Scientific Reports · doi:10.1038/s41598-024-84607-6 · Cited by 10
“AURKA is a mitotic serine/threonine kinase that promotes pancreatic cancer progression by inducing the epithelial-to-mesenchymal transition and chemoresistance via the phosphorylation/activation of Twist1 26–28 .”
Developing a Predictive Model for Metastatic Potential in Pancreatic Neuroendocrine Tumor
Greenberg, J. A., Shah, Y., Ivanov, N. A., Marshall, T. E., Kulm, S., Williams, J., Tran, C. G., Scognamiglio, T., Heymann, J. J., Lee-Saxton, Y. J., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae380 · Cited by 9
Yellapu, N. K., Pulaganti, M., & Pakala, S. B. (2016) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2016.1216894 · Cited by 8
“All these potential interacting elements were observed to be associated with the development of cancers (Chan et al., 2010; Elsheikh et al., 2008; Furukawa et al., 2006; Kamran, Patil, & Gude, 2013; King, Suto, & Li, 2012).”
BackgroundLong Non-Coding RNAs Associated with Mitogen-Activated Protein Kinase in Human Pancreatic Cancer
Ishikawa, T., Fukushige, S., Saiki, Y., Hirose, K., Hiyoshi, T., Ogawa, T., Katori, Y., & Furukawa, T. (2023) · Cancers · doi:10.3390/cancers15010303 · Cited by 8
Self-citationRole of the STK15 Phe31Ile polymorphism in renal cell carcinoma
Hammerschmied, C. G., Stoehr, R., Walter, B., Wieland, W. F., Hartmann, A., Blaszyk, H., & Denzinger, S. (2007) · Oncology Reports · doi:10.3892/or.17.1.3 · Cited by 8
Samimi, H., Tavakoli, R., Fallah, P., Sohi, A. N., Shirkouhi, M. A., Naderi, M., & Haghpanah, V. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02813-6 · Cited by 8
Differential Response and Resistance to KRAS-Targeted Therapy
Liu, Z., Lenz, H., Yu, J., & Zhang, L. (2025) · Molecular Carcinogenesis · doi:10.1002/mc.23908 · Cited by 7
“On one hand, aberrant activation of KRAS and downstream MAPK/ ERK signaling promotes AURKA overexpression [132 – 134].”
Exact association test for small size sequencing data
Lee, J., Lee, S., Jang, J., & Park, T. (2018) · BMC Medical Genomics · doi:10.1186/s12920-018-0344-z · Cited by 8
“MAPK1 is constitutively activated by frequent mutation and plays key roles in pancreatic carcinogenesis and progression [21].”
BackgroundKumari, P., Beeraka, N. M., Tengli, A., Gurupadayya, B., Baath, R. K., & Patil, M. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867330666230503124408 · Cited by 7
Bisphenol A-sulfate conjugate disrupts AURKA transcription and cell cycle in BeWo cytotrophoblasts
Fujiki, J., Uchida, M., Tsunoda, S., Maeda, N., Inoue, H., Yokota, H., & Iwano, H. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2022.111561 · Cited by 7
Integrative Analysis of Cancer Omics Data for Prognosis Modeling
Wang, S., Wu, M., & Ma, S. (2019) · Genes · doi:10.3390/genes10080604 · Cited by 8
“Besides, MAPK1 is involved in EGFR tyrosine kinase inhibitor resistance [25], which importantly contributes to the etiology of various types of cancer, such as pancreatic cancer [26], paediatric acute lymphoblastic leukemia [27], and others.”
BackgroundDeciphering ETS2: An indispensable conduit to cancer
John, S., Kalathil, D., Pothuraju, R., & Nair, S. A. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189368 · Cited by 7
Kim, Y. N., Patil, K., Ma, J., Dufek, G. A., & Pai, S. B. (2023) · Biomedicines · doi:10.3390/biomedicines11061716 · Cited by 6
“Moreover, Aurora kinase A has been reported as a downstream target in the MAPK1/ERK2 signaling pathway in pancreatic cancer [22].”
BackgroundSignatures of Co-Deregulated Genes and Their Transcriptional Regulators in Kidney Cancers
Ioannou, I., Chatziantoniou, A., Drenios, C., Christodoulou, P., Kourti, M., & Zaravinos, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076577 · Cited by 7
“After its activation, it translocates into the nucleus of stimulated cells, where it phosphorylates various nuclear targets, including Aurora-A kinase gene (AURKA) [42].”
BackgroundInhibiting of TACC3 Promotes Cell Proliferation, Cell Invasion and the EMT Pathway in Breast Cancer
Huo, Q., Chen, S., Li, Z., Wang, J., Li, J., & Xie, N. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.640078 · Cited by 6
Integrated analysis of senescence-associated genes in pancreatic ductal adenocarcinoma
Zhu, Z.-G., Chen, L., Miao, D.-L., Jin, Y., & Wu, Q. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.941389 · Cited by 5
“CENPA has been reported to be an oncogene in various malignancies, including PDAC (Furukawa et al., 2006; Zhang et al., 2020; Han et al., 2021; Wang et al., 2021).”
BackgroundLuo, S., Gan, L., Luo, Y., Zhang, Z., Li, L., Wang, H., Li, T., Chen, Q., Huang, Y., He, J. G., et al. (2021) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2021.3098 · Cited by 5
Transcriptome-Guided Drug Repurposing for Aggressive SCCs
Zauner, R., Wimmer, M. A., Dorfer, S., Ablinger, M., Koller, U., Hofbauer, J. P., Guttmann‐Gruber, C., Bauer, J. W., & Wally, V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23021007 · Cited by 5
“MAPK that contribute to the regulation of cell cycle progression [29].”
BackgroundAurora Kinases: New Molecular Targets for the Therapy of Aggressive Thyroid Cancers
Baldini, E., Tuccilli, C., Sorrenti, S., Mascagni, D., Arcieri, S., Filippini, A., & Ulisse, S. (2016) · InTech eBooks · doi:10.5772/64597 · Cited by 5
“AURKB promoter activity is positively increased by transcription factors such the ETS2 via ETS-binding sites present in its sequence [46, 47].”
Background
Metadata
- Authors
- Furukawa, T., Kanai, N., Shiwaku, H. O., Soga, N., Uehara, A., & Horii, A.
- Affiliations
- Tokyo Women's Medical University (JP)
- Tohoku University (JP)
- Corresponding author
- Furukawa, T
- Venue
- Oncogene
- Published
- 2006-03-13
- Volume
- 25
- Issue
- 35
- Pages
- 4831-4839
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2048245178
- Cited by
- 135
- References
- 50
- Citations by year
- 2026: 1 · 2025: 8 · 2024: 6 · 2023: 9 · 2022: 10 · 2021: 9 · 2020: 6 · 2019: 5 · 2018: 8 · 2017: 4 · 2016: 8 · 2015: 4 · 2014: 8 · 2013: 4 · 2012: 6
- FWCI
- 4.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pancreas Research Foundation of Japan
- Foundation for Promotion of Cancer Research
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Keywords
- AURKA, pancreatic cancer, KRAS mutation, ETS2, downstream target genes, mitosis, gene expression profiling, promoter activity, TPX2, CENP-A
- MeSH terms
- Cell Line, Cell Line, Transformed, Humans, Pancreatic Neoplasms, Gene Expression Regulation, Neoplastic, Protein Tyrosine Phosphatases, Protein Serine-Threonine Kinases, Mitogen-Activated Protein Kinase 1, Gene Expression Profiling, MAP Kinase Signaling System, Cell Line, Tumor, Dual Specificity Phosphatase 6, Aurora Kinase A, Aurora Kinase B, Aurora Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.